Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2005 16:48 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Receives Clarification from FDA About Clinical Program; Cash Reserves Update

PALATINE, Ill., Oct. 17, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced receipt from the United States Food and Drug Administration ("FDA") communications clarifying...
October 03, 2005 18:07 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Receives Communication from FDA

PALATINE, Ill., Oct. 3, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company has received correspondence from the United States Food and Drug Administration...
September 16, 2005 09:30 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Secures Bridge Funding

PALATINE, Ill, Sept. 16, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company has secured $500,000 under a term Loan Agreement (the "Loan") with Essex...
July 14, 2005 16:30 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Reports Financial Results For Second Quarter 2005 and Commercial Strategy/Cash Reserves Update

PALATINE, Ill., July 14, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $1.4 million or $0.06 per share for the quarter ended June 30, 2005 compared to a...
June 22, 2005 17:33 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Secures Bridge Funding

PALATINE, Ill., June 22, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company has secured $1 million under a term Loan Agreement (the "Loan") with Essex...
May 02, 2005 16:05 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Reports Results for First Quarter 2005

PALATINE, Ill., May 2, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced net loss of $1,948,000 for the quarter ended March 31, 2005 compared to a net income of $680,000...
April 15, 2005 16:00 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Announces Commencement of Clinical Trials for Product Candidate No. 2 and Updates Commercial Strategy and Cash Reserves

PALATINE, Ill., April 15, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced the initiation of a clinical trial for the Company's Product Candidate No. 2. Product Candidate...
February 28, 2005 17:13 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Reports Financial Results, Development Progress and Strategy Update

PALATINE, Ill., Feb. 28, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $2.1 million or $0.09 per share for the three months ending December 31, 2004...
November 12, 2004 17:05 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Reports Results For Third Quarter 2004, Acceptance of IND Filing by FDA and Commencement of Clinical Trials

PALATINE, Ill., Nov. 12, 2004 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $(51,480,000) or $(2.35) per share for the quarter ended September 30, 2004...
August 17, 2004 11:59 ET | Source: Acura Pharmaceuticals Inc.

Acura Pharmaceuticals, Inc. Announces New Stock Symbol

PALATINE, Ill., Aug. 17, 2004 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company's common stock will trade under the symbol "ACUR" effective immediately. This...